未登录

R

Robert S. Kerbel

Sunnybrook Research Institute

H指数:111

被引数:5.4万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Modulation of fibronectin extracellular matrix enhances anti-tumor efficacy of immune checkpoint blockade

调节纤维连接蛋白细胞外基质可增强免疫检查点抑制剂的抗肿瘤疗效

Cell Reports Medicine

IF10.6

2025-09-080

OAAI

Metronomic chemotherapy and drug repurposing: Two sides of an oncology coin to reduce host and financial toxicity

常规化疗和药物重定位：减少宿主和经济毒性的肿瘤学双刃剑

IF10.1

2025-03-010

PRE

Antiangiogenic-immune-checkpoint inhibitor combinations: lessons from phase III clinical trials

抗血管生成-免疫检查点抑制剂组合: III期临床试验的经验教训

NATURE REVIEWS CLINICAL ONCOLOGY

IF82.2

2024-04-1014

PRE

Potentiating salvage radiotherapy in radiorecurrent prostate cancer through anti-CTLA4 therapy: Implications from a syngeneic model

CANCER RESEARCH

IF16.6

2024-03-220

PRE

Metronomic gemcitabine plus neratinib effectively inhibits the growth of human Her-2 positive breast cancer cells intracranially implanted into immunodeficient mice

CANCER RESEARCH

IF16.6

2023-04-040

PRE

A unique autophosphorylation site on Tie2/Tek mediates Dok-R phosphotyrosine binding domain binding and function

MOLECULAR AND CELLULAR BIOLOGY

IF2.7

2023-03-2793

OAAI

Gene expression analysis of tumor spheroids reveals a role for suppressed DNA mismatch repair in multicellular resistance to alkylating agents

MOLECULAR AND CELLULAR BIOLOGY

IF2.7

2023-03-2749

OAAI

ErbB2/Her2-dependent downregulation of a cell death-promoting protein BLNK in breast cancer cells is required for 3D breast tumor growth

CELL DEATH & DISEASE

IF9.6

2022-08-067

OAAI

Tumors resurrect an embryonic vascular program to escape immunity

SCIENCE IMMUNOLOGY

IF16.3

2022-01-1435

PRE

On coalescent angiogenesis and the remarkable flexibility of blood vessels

IF9.2

2022-01-076

OA

Adjuvant metronomic chemotherapy for locoregionally advanced nasopharyngeal carcinoma Comment

IF88.5

2021-07-015

PREAI

Ang2 inhibitors and Tie2 activators: potential therapeutics in perioperative treatment of early stage cancer

EMBO MOLECULAR MEDICINE

IF8.3

2021-06-1425

OAAI

Microbubble mediated focused ultrasound therapy enhances the antitumor potency and durability of anti-PD-L1 checkpoint blockade

CANCER RESEARCH

IF16.6

2020-08-151

PRE

Metronomic chemotherapy offsets HIFα induction upon maximum-tolerated dose in metastatic cancers

EMBO MOLECULAR MEDICINE

IF8.3

2020-07-2022

OAAI

Immunostimulatory and anti-tumor metronomic cyclophosphamide regimens assessed in primary orthotopic and metastatic murine breast cancer

NPJ BREAST CANCER

IF7.6

2020-07-2023

OAAI

A new Tie1 targeted antibody blocks tumor cell extravasation and metastasis

EMBO MOLECULAR MEDICINE

IF8.3

2020-05-137

OAAI

Microparticles from tumors exposed to radiation promote immune evasion in part by PD-L1

IF7.3

2019-08-2940

OAAI

Variable impact of three different antiangiogenic drugs alone or in combination with chemotherapy on multiple bone marrow-derived cell populations involved in angiogenesis and immunity

IF9.2

2019-08-282

PREAI

Durability of cell line xenograft resection models to interrogate tumor micro-environment targeting agents

SCIENTIFIC REPORTS

IF3.9

2019-06-245

OAAI

Vessel co-option in cancer

癌症中的血管共同选择

NATURE REVIEWS CLINICAL ONCOLOGY

IF82.2

2019-02-28308

PREAI